Biovet JSC (LTS:0III) Common Stock: лв6.78 Mil (As of Dec. 2016)


What is Biovet JSC Common Stock?

Biovet JSC LTS:0III Common Stock is лв6.78 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's quarterly common stock stayed the same from Jun. 2016 (лв6.78 Mil) to Sep. 2016 (лв6.78 Mil) and stayed the same from Sep. 2016 (лв6.78 Mil) to Dec. 2016 (лв6.78 Mil).

Biovet JSC's annual common stock stayed the same from Dec. 2014 (лв6.78 Mil) to Dec. 2015 (лв6.78 Mil) and stayed the same from Dec. 2015 (лв6.78 Mil) to Dec. 2016 (лв6.78 Mil).

Biovet JSC Common Stock Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Common Stock Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Common Stock
Get a 7-Day Free Trial 6.78 6.78 6.78 6.78 6.78

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.78 6.78 6.78 6.78 6.78

Biovet JSC Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of лв6.78 Mil mean?
Biovet JSC (LTS:0III) has a Common Stock of лв6.78 Mil as of Dec. 2016. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Common Stock too high?
Biovet JSC's current Common Stock is лв6.78 Mil.
How does Biovet JSC's Common Stock compare to ADMP and AGRX?
Biovet JSC's Common Stock of лв6.78 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biovet JSC and its competitors. Biovet JSC's current Common Stock is лв6.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Common Stock of лв6.78 Mil. The current Common Stock is лв6.78 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Common Stock is лв6.78 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.